- ADJUNCT PROFESSOR Neuroscience
- ADJUNCT PROFESSOR Psychiatry
- ADJUNCT PROFESSOR Structural and Chemical Biology
Dana Farber Cancer Institute
Laurea, University of Pavia
Ph.D., University of Genoa
- After training in biology and immunology, I have now focused my interest on how the brain changes in response to external and internal stimuli. In particular, I am intrigued by how memories are formed, stored and elaborated. Memory is a fundamental biological function and a critical component of our identity. As such, it involves our brain, mind and psyche. I am interested in exploring the biological mechanisms of memory and their integration into complex behavioral manifestations. I am also interested in applying this knowledge in order to understand how memory becomes an integral part of pathologies such as addiction and trauma.
Specific Clinical/Research Interest: Molecular mechanisms of long-term memory
Current Students: MD/PhD: Dillon Chen; PhD: Dhananjay Bambah-mukku, Sarah Stern
Postdoctoral Fellows: Carmen Inda, Akinobu Suzuki
Research Personnel: Gabriella Pollonini
Summary of Research Studies:
A fascinating aspect of learning and memory is its biological basis. In order to occur, long-term memory requires an initial and relatively brief temporal phase during which gene expression is essential (consolidation phase). This is a universal feature of long-term memory processes, which is found in several different forms of memory and conserved throughout evolution. We are interested in the identification and functional characterization of the gene cascade activated during memory consolidation. In addition, our studies aim at determining where in the brain and when following learning this gene cascade is activated.
Our current approach is focused on differential gene expression screenings in specific brain areas of control, naive animals vs. animals that underwent learning. The identification of memory gene candidates is followed by molecular and functional studies aimed at defining the role of each identified component. We are also interested in understanding the molecular mechanisms that accompany memory reorganization after recall. Old and stored memories can become vulnerable if they are recalled (reactivated). These findings led to the hypothesis that when an old memory is reactivated it again becomes labile, and it does so in order to incorporate new information. This process of returning to a labile state after recall can be useful to develop therapeutic approaches for treating traumatic memories (traumatic stress disorders). We are working to understand which brain regions and molecular mechanisms underlie memory destabilization and re-stabilization after recall.
A clinically relevant model in which we apply these studies is addiction.. When drug addicts are exposed to cues that remind them of the rewarding state of the drug, they experience a strong craving response. This compulsive response seems to use mechanisms similar to those involved in memory formation. We are working on the identification and characterization of the molecular changes that occur in the brain when an addictive response is formed. Using rat models of conditioning to a drug of abuse (morphine), we aim at identifying which gene and protein are essential for making a brain addicted and which strategy we can use to disrupt this response. Areas of interest include: Learning and memory responses in vivo (behavior); Analysis of patterns of gene expression (gene arrays); temporally and anatomically restricted gene manipulation; memory reactivation, amnesia, addiction.Visit Dr. Cristina Alberini's Neurobiology of Learning and Memory for more information.
Chen DY, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku Blitzer RD, Alberini CM. A critical role for IGF-II in memory consolidation and Enhancement. . Nature 2011; 469: 491-497.
Inda MC, Muravieva E, Alberini CM. Memory retrieval and the passage of time: from reconsolidation and strengthening to extinction.. Journal of Neuroscience 2011; 31: 1635-1643.
Bibb JA, Mayford MR, Tsien JZ, Alberini CM. Cognition enhancement strategies.. J. Neurosci. 2010; 30: 14987-14992.
Alberini CM. Long-term Memories: The Good, the Bad, and the Ugly.. Dana Press 2010;.
Taubenfeld SM, Muravieva EV, Garcia-Osta A, Alberini CM. Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner.. Proc Natl Acad Sci U S A. 2010; 107: 12345-12350.
Muravieva EV, Alberini CM. Limited efficacy of propranolol on the reconsolidation of fear memories.. Learn Mem. 2010; 17: 306-313.
Alberini CM, Garcia-Osta A. Amyloid beta mediates memory formation.. Learn Mem. 2009; 16: 267-272.
Alberini CM. Transcription factors in long-term memory and synaptic plasticity. [review]. Physiol Rev. 2009; 89: 121-145.
Taubenfeld SM, Riceberg JS, New AS, Alberini CM. Preclinical assessment for selectively disrupting a traumatic memory via postretrieval inhibition of glucocorticoid receptors.. Biol Psychiatry. 2009; 65: 249-257.
Alberini CM. The role of protein synthesis during the labile phases of memory: revisiting the skepticism. [review]. Neurobiol Learn Mem. 2008; 89: 234-246.
Pollonini G, Gao V, Rabe A, Palminiello S, Albertini G, Albertini CM. Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.. Neuroscience 2008; 156: 99-106.
Milekic MH, Pollonini G, Albertini CM. Temporal requirement of C/EBPbeta in the amygdala following reactivation but not acquisition of inhibitory avoidance.. Learn Mem. 2007; 14: 504-504.
Tronel S, Alberini CM. Persistent disruption of a traumatic memory by postretrieval inactivation of glucocorticoid receptors in the amygdala.. Biol Psychiatry. 2007; 62: 33-39.
Alberini CM, Milekic MH, Tronel S. Mechanisms of memory stabilization and de-stabilization. [review]. Cell Mol Life Sci. 2006; 63: 999-1008.
Garcia-Osta A, Tsokas P, Pollonini G, Landau EM, Blitzer R, Alberini CM. MuSK expressed in the brain mediates cholinergic responses, synaptic plasticity, and memory formation.. J Neurosci. 2006; 26: 7919-7932.
Milekic MH, Brown SD, Castellini C, Albertini CM. Persistent disruption of an established morphine conditioned place preference.. J Neurosci. 2006; 26: 3010-3020.
Alberini CM. Mechanisms of memory stabilization: are consolidation and reconsolidation similar or distinct processes? [review]. Trends Neurosci. 2005; 28: 51-56.
Tronel S, Milekic MH, Alberini CM. Linking new information to a reactivated memory requires consolidation and not reconsolidation mechanisms.. PLoS Biol. 2005; 3(9): e293.
Milekic MH, Alberini CM. Temporally graded requirement for protein synthesis following memory reactivation.. Neuron 2002; 36: 521-525.
Taubenfeld SM, Stevens KA, Pollonini G, Ruggiero J, Alberini CM. Profound molecular changes following hippocampal slice preparation: loss of AMPA receptor subunits and uncoupled mRNA/protein expression.. J Neurochem. 2002; 81: 1348-1360.
Taubenfeld SM, Milekic MH, Monti B, Alberini CM. The consolidation of new but not reactivated memory requires hippocampal C/EBPbeta.. Nat Neurosci. 4; 4: 813-818.
Taubenfeld SM, Wiig KA, Monti B, Dolan B, Pollonini G, Alberini CM. Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein [beta] and [delta] Co-localizes with phosphorylated cAMP response element-binding protein and accompanies long-term memory consolidation.. J Neurosci. 2001; 21: 84-91.
Taubenfeld SM, Wiig KA, Bear MF, Alberini CM. A molecular correlate of memory and amnesia in the hippocampus.. Nat Neurosci. 1999; 2: 309-310.
Alberini CM. Genes to remember. [review]. J Exp Biol. 1999;(202): 2887-2891.
Alberini CM, Ghirardi M, Metz R, Kandel ER. C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia.. Cell. 1994; 76: 1099-1114.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Alberini did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.